(Q40081519)

17 September 2017

title

An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16. (English)

1 reference

17 September 2017

1 reference

Griffith C

1

1 reference

17 September 2017

Noonan S

series ordinal

2

1 reference

17 September 2017

Lou E

series ordinal

3

1 reference

17 September 2017

Shillitoe EJ

series ordinal

4

1 reference

17 September 2017

publication date

14 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

14

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

985-993

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7701089

17 September 2017

exact match

0 references

cites work

Herpes simplex virus type-1-induced activation of myeloid dendritic cells: the roles of virus cell interaction and paracrine type I IFN secretion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Effect of herpes simplex virus type-1 on growth of oral cancer in an immunocompetent, orthotopic mouse model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Transcriptional targeting of herpes simplex virus for cell-specific replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Strength and specificity of different gene promoters in oral cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Effects of herpes simplex virus on human oral cancer cells, and potential use of mutant viruses in therapy of oral cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Can flow cytometrically determined DNA ploidy and S-phase fraction predict regional metastasis in squamous cell carcinoma of the oral cavity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Abnormal properties of an immediate early polypeptide in cells infected with the herpes simplex virus type 1 mutant tsK

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Regulation of herpes simplex virus 1 replication using tumor-associated promoters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Detailed analysis of the mRNAs mapping in the short unique region of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Suppression of human papillomavirus gene expression in vitro and in vivo by herpes simplex virus type 2 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Replication and interaction of herpes simplex virus and human papillomavirus in differentiating host epithelial tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

The responsiveness of human papillomavirus upstream regulatory regions to herpes simplex virus immediate early proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and a phorbol ester

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701089

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701089

1 reference

Dimensions Publication ID

17 September 2017

1015389884

0 references

1 reference